Sign inJoin waitlistJoin the waitlist

Chamindra Laverty

Clinical Director of Muscle Disease · University of California (San Diego) Medical Center

Credentials: · · · · ·

History

University of California (San Diego) Medical Center Fellowship
Present
Muscle Disease · University of California (San Diego) Medical Center
Present
University of California (San Diego) Medical Center
Present

University of California-Los Angeles
2009–2010
University of California-Los Angeles
2006–2009
Hahnemann University Hospital -American Academic Health System
2002–2003
Drexel University College of Medicine
1998–2002

Research

Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis
Nature Medicine · 2021 · 135 citations
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Neurology · 2024 · 113 citations
BAG3 myofibrillar myopathy presenting with cardiomyopathy
Case report · Neuromuscular Disorders · 2015 · First of 10 authors · Corresponding · 70 citations

Carsten Bonnemann
6 papers
Katherine Mathews
5 papers
Craig McDonald
4 papers
Dimah Saade
4 papers · 1 as a fellow
Matthew Wicklund
4 papers
NJ
Nicholas Johnson
4 papers
Perry Shieh
4 papers
Russell Butterfield
4 papers
Ying Hu
4 papers
Andrea Swenson
3 papers
Anne Connolly
3 papers
Bakri Elsheikh
3 papers

Clinical trials

A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Site PI · Recruiting · Phase 1, Phase 2
Solid Biosciences Inc.
2024–2031
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Site PI · Recruiting
Virginia Commonwealth University
2019–2026
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Site PI · Recruiting
Novartis Pharmaceuticals
2018–2038